New Therapies of Neovascular AMD—Beyond Anti-VEGFs
Neovascular age-related macular degeneration (nAMD) is one of the leading causes of blindness among the aging population. The current treatment options for nAMD include intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF). However, standardized frequent administration of an...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2018-07-01
|
| Series: | Vision |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2411-5150/2/3/31 |